Activity of Entrectinib in a Patient With the First Reported NTRK Fusion in Neuroendocrine Cancer

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2017.7029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Entrectinib Effective Across NTRK Fusion–Positive Cancers

Cancer Discovery
Oncology
2018English

First Reported Case of Omenn Syndrome in a Patient With Reticular Dysgenesis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2013English

Comprehensive Genomic Profiling Identifies Novel NTRK Fusions in Neuroendocrine Tumors

Oncotarget
Oncology
2018English

P2.03-09 the Real World of NTRK Fusion Data in the Chinese Lung Cancer Populations: A Multicenter Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

Angioedema in a Patient With Neuroendocrine Tumour

BMJ Case Reports
Medicine
2017English

Patient‐Reported Comorbidity and Survival in Older Adults With Cancer

Oncologist
Cancer ResearchMedicineOncology
2017English

Patient-Reported Outcomes in Head and Neck Cancer: Prospective Multi-Institutional Patient-Reported Toxicity

Patient Related Outcome Measures
2018English

First Reported Case of Aspergillus Granulosus Infection in a Cardiac Transplant Patient.

Journal of Clinical Microbiology
Microbiology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy